Presenilins 1 (PS1) and 2 (PS2) are multispanning transmembrane proteins associated with famnilial Alzheimer disease (FAD). They are developmentally regulated, being expressed at highest levels during neuronal differentiation and are sustained at a lower level throughout life. We investigated the distribution and metabolism of endogenous murine PS 1 as well as human wild-type (wtPSl) and the familial AD Metl46Leu (M146L) mutant presenilins in dissociated cultures of hippocampal neurons derived from control and transgenic mice. We found that the PS1 endoproteolytic fragments and, to a lesser extent, the full-length protein, were expressed as early as day 3 post-plating. Both species increased until the cells were fully differentiated at day 12. Confocal microscopy revealed that presenilin is present in the Golgi and endoplasmic reticulum and, as in punctate, vesicle-like structures within developing neurites and growth cones. Using a human-specific PSI antibody, we were able to independently examine the distribution of the transgenic protein which, although similar to the endogenous, showed some unique qualities. These included (i) some heterogeneity in the proteolytic fragments of human PSI; (ii) significantly reduced levels of full-length human PS 1, possibly as a result of preferential processing; and (iii) a more discrete intracellular distribution of human PS1. Colocalization with organellespecific proteins revealed that PSI was located in a diffuse staining pattern in the MAP2-positive dendrites and in a punctate manner in GAP43-positive axons. PSI showed considerable overlap with GAP43, particularly at the growth cones. Similar patterns of PSI distribution were detected in cultures derived from transgenic animals expressing human wild-type or mutant presenilins. The studies demonstrate that mutant presenilins are not grossly different in their processing or distribution within cultured neurons, which may represent more physiological models as compared to transfection systems. Our data also suggest that the molecular pathology associated with PS 1 mutations results from subtle alterations in presenilin function, which can be further investigated using these transgenic neuronal cell culture models.
Introduction
The most common form of early onset familial Alzheimer's disease (FAD) is associated with missense mutations in the presenilin family of proteins (1) (2) (3) (4) . Presenilin-1 (PS 1) and presenilin-2 (PS2) are integral membrane proteins containing multiple transmembrane domains and sharing -67% homology, diverging most substantially in the nonmembranous sequences. PSI and PS2 are expressed in the brain as well as in most peripheral tissues, with PSI having a wider expression pattern compared to PS2 (1, 4) . Both presenilins are proteolytically cleaved into 30 kD N-and 18 kD C-terminal fragments (5) . Current evidence indicates that these two proteolytic products remain associated with each other after cleavage (7) (8) (9) . Brain expression of PSI is highest in the cerebrum, hippocampus, and entorhinal cortices (10) (11) (12) (13) (14) (15) . There are reports of localization of PSI to neurofibrillary tangle-bearing neurons (16) and to dystrophic neurites of amyloid plaques (17, 18) in Alzheimer's brains. Presenilins in the CNS are predominantly localized in neuronal cell bodies and processes, while relatively lower levels are found in astrocytes and blood vessels (10, 11, 13, 17) . In both cultured neurons and transfected cells, PSI has been found within the nuclear membrane, the endoplasmic reticulum (ER), the Golgi complex and in some small unidentified vesicles (15, (19) (20) (21) .
Mutations of the presenilins do not seem to affect the overall distribution of these proteins in brain (16) (17) (18) 22) . However, PSI mutations have been associated with abnormalities in amyloid precursor protein (APP) processing, leading to an increase in the longer amyloid-,B 1-42 species (A,B42) in vivo and in vitro (6, (23) (24) (25) (26) (27) (28) (29) . In addition, PS I is essential for AP3 generation, as shown by a recent study of APP metabolism in neuronal cultures derived from PS1 knock-out animals (30) .
Full-length presenilin protein and its fragments have been implicated in a number of functional pathways such as protein transport, apoptosis, intracellular signaling, and/or calcium regulation (1, (31) (32) (33) (34) (35) . These functional aspects are based largely on sequence homologies (e.g., to the C. elegans protein sel- 12 which is involved in the Notch/lin-12 signaling pathway; 36, 37) . This relationship has been strengthened by the observation that the sel-12 mutant phenotype can be rescued by either PSI or PS2 (38, 39) . Links to Notch signaling pathways have been emphasized by the recent demonstration of PS1 -dependent cleavage and activity of Notch (40) (41) (42) . In the brain, PS1 expression increases in parallel with neuronal differentiation and may therefore be instrumental in establishing and maintaining neurons (12, (43) (44) (45) . Furthermore, PSI knock-outs produce a lack of somite segmentation, stubby tail, and brain hemorrhage, resulting in fetal lethality (33, 46) , similar to the phenotype associated with deletion of the important developmental gene Notchl (47) .
The current study was performed to elucidate the distribution and processing of PSI in differentiating hippocampal neurons in dissociated culture. For this purpose we examined endogenous murine PS I and, in cultures from transgenic animals, the wild-type human (wtPS 1) and the missense mutant Metl46Leu.
Materials and Methods
Transgenic Animals and Neuronal Cultures Transgenic mice expressing human wtPS 1 or MetI 46Leu (M146L) mutant PS I were driven by the prion promoter as previously described (26) . Mouse hippocampal neurons were cultured using a protocol adapted from Goslin and Banker (48) . Briefly, E18 mouse hippocampi were trypsinized, dissociated with fire-polished Pasteur pipets, and plated onto poly-L-lysine (Sigma)-coated culture dishes or glass coverslips. Cells were incubated for the first 4 hr in minimum essential medium (MEM) with 10% horse serum and then maintained in serum-free neurobasal medium with B7 supplement (Gibco). Coverslips were transferred to plates containing a confluent layer of glial cells. All cells were incubated at 370C with 5% CO2.
Antibodies
The human specific NTI monoclonal antibody (MAb) recognizes the unique PSI sequence contained within residues 41-49. Rabbit polyclonal Ab14 was raised against an N-terminal synthetic peptide (residues of PSI) as previously described (5 Examination of PS 1 expression in transgenic animals indicated a similar pattern for both the human wtPSI and the M146L mutants ( Fig. 2A , lanes 6, 7). With short exposures of the blots, it was revealed that the C-terminal band contained a doublet that included a slightly larger band at -20 kD (not shown). This heterogeneity may be due to alternate cleavage or to the separation of human and mouse PS 1 fragments, as previously reported (50) .
Western blots using Abi4 (Fig. 2B ) indicated a pattern for the PS I -NTF that was comparable to that observed for the PS1-CTF. A small amount of PSI -NTF was present at 4 hr post-plating and at day 1 (Fig. 2B , lane 1) and increased in intensity at later stages of development (Fig. 2B , lanes [3] [4] [5] . An N-terminal immunoreactive -55 kD species was detected at these later stages (Fig. 2B , days [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . The origin of this band is unclear and is similar to that observed with the C-terminal antibody (17.2) and may represent a post-translationally modified PSI. As with the C-terminal specific antisera, a 98 kD immunoreactive band was observed when AbI4 immunoblotting was performed at 4 hr post-plating (arrow, Fig. 2B (Fig. 2C) . Unlike the endogenous mouse protein, full-length human transgenic PSI was present at significantly lower levels even at the final stages of neuronal development (e.g., day 12). This suggests that the full-length protein observed with humanmouse cross-reactive antibodies corresponds primarily to the endogenous murine PSI (see Fig. 2B ). At day 3 post-plating, only the -33 kD species was observed in the wtPS 1 animals (Fig. 2C, lane 1) , with a similar pattern being observed in the Mi46L mutants (Fig. 2C, lane 3 The subcellular localization of PS I was examined by immunofluorescence microscopy during neuronal development through stages 1-5 as described by Dotti et al. (53) . At 4 hr after plating, cultures labeled with the C-terminal antibody 17 .2 revealed that PSI was largely confined to the perinuclear space within the cell body of these stage 1 neurons, but labeling could also be observed within newly extending processes (Fig. 3A) . From stages 2 through 4 ( Fig. 3B-D) , intense immunoreactivity was observed within the cell body and extending into the hillocks of some neuritic processes. In addition, an intense punctate staining was observed within a subset of the developing growth cones of these early-to mid-stage neurons (Fig. 3B-D pear along the shafts of some of neuritic processes but the intensity was substantially weaker than that present around the nucleus and at growth cones (see, for example, Fig. 3D ). At fully differentiated stage 5, the neuronal PSI staining within the perinuclear space was similar to less developed neurons (Fig. 3E) . In contrast to the early stages, labeling within the processes on day 12 had a more well-defined punctate appearance, which was significantly more intense than, for example, the stage 4 cultures (compare Fig. 3E to Fig. 3D ). This intense, possibly vesicular, staining was also observed in many more processes in the fully developed neurons and displayed a diffuse pattern in the larger dendrites that contrasted with the widely scattered staining in the narrow axon-like processes. These findings are consistent with the data from studies of endogenous rat PSI and PS2 in cultured neurons as described by Capell and colleagues (51) . Visualization of endogenous PSI-NTF with Ab14 revealed an identical pattern of PSI immunolocalization in stages [1] [2] [3] [4] (not shown). In fully differentiated stage 5 cultures, (Fig. 4A) . Staining for the PSI-CTF (Fig. 4B ) in the same cell indicated a partial overlap with BiP ( Fig. 4C) , which is consistent with the subcellular localization of PS 1 in transfected and wild-type cells (19) (20) (21) . However, the murine neurons did not display a complete overlap between BiP and endogenous PS1. This suggests that PS 1 may be contained within an ER subcompartment. The cisGolgi network (CGN) marker p58 also displayed strong perinuclear staining (Fig. 4D) as expected (47) . Double labeling for p58 and the PS1-CTF using antibody 17.2 ( Fig. 4E ) revealed a virtually complete overlap of the two staining patterns (Fig. 4F ). This PSI-Golgi immunoreactivity was apparently restricted to the cis-component since double labeling with antibodies to TGN38 and PS1 indicated little obvious codistribution (data not shown). The localization of human and murine PS 1 within processes was examined using antibodies to the cytoskeletal protein, MAP2, and the growth cone protein, GAP43. In fully differentiated hippocampal neurons, MAP2 staining was widely distributed within dendrites (Fig. 5A) as reported (53) (54) (55) . Double labeling with antibodies to MAP2 and PSI indicated an extensive colocalization of the two proteins within the MAP2-reactive processes (Fig. 5A) . However, the PS1 immunoreactivity was also apparent in the MAP2 -negative axons (Fig. 5A,  arrows) . This indicates that PS1 maintains a widespread level of expression within various types of processes.
PSI distribution within neurite terminals was investigated using antibodies to GAP43 and PS1. GAP43 immunoreactivity was observed in axons and extending growth cones (Fig. 5B) , consistent with previous investigations (48, 55, 56) . Immunolabeling for PS1 demonstrated a partial coincidence of staining for the two proteins within the axonal processes. It is also possible that the discrete axonal staining could represent synapse-like structures containing PSI, since GAP43-positive domains can represent axon-dendrite contacts. This possibility would be consistent with the observation that intense PS1 immunoreactivity within the growth cones often overlapped with the GAP43 immunoreactivity (Fig. 5B, arrow) . While some PS1-positive but GAP43-negative terminals were observed, these represented only a small percentage of the terminals. Double labeling for PSI and synaptophysin, a synaptic vesicle protein of nerve terminals, did not significantly overlap (not shown). This observation is consistent with the failure of PSI to cofractionate with small synaptic vesicles (S. Petanceska and S. Gandy, unpublished results).
Comparing the Subcellular Localization of Human Wild-Type and Mutant PS1 The distribution of PS 1 in the transgenic neurons expressing human wtPS I and the M146L mutant was also investigated to determine whether the human proteins localized in a markedly different fashion than did the endogenous murine proteins. These studies were undertaken using the human-specific MAb NT1. In this case, fully differentiated neurons displayed a perinuclear staining similar to that seen with the control, nontransgenic cultures (Fig. 6) . In contrast to the staining observed with the polyclonal antisera, NTI revealed immunoreactivity within the processes which appeared to be more intense and punctate as compared to the pattern present in neurons expressing endogenous mouse PS1. Normal nontransgenic mouse hippocampal neurons did not show any immunoreactivity with NT1, indicating that the labeling observed in the Fig. 4 . Colocliation of PSI with markers to the endoplasmic reticulum (ER) and CGN compartments. Differentiated neurons (stage 5) were double labeled with a monoclonal antibody to the ER protein, BiP (A), and the PS1 C-terminal fragment using the 17.2 antiserum (B) with a color overlay (C), with BiP in green and PSI in red. Similar cultures were examined with the CGN marker, p58 (D) and the 17.2 antiserum (E) to demonstrate the degree of overlap between the two proteins. A color overlay with p58 in green and PSI in red is shown in F. Fig. 5 . Colocalization of PSI with neuronal markers. Differentiated neurons were double labeled with a monoclonal antibody to microtubule-associated protein 2 (MAP2) (red) and with the PSI C-terminal specific antibody 17.2 (green). The unique axonal distribution of the PS1 protein is indicated by the arrows (A). Similar cultures were double labeled with a monoclonal antibody to the growth cone marker GAP43 (red) and PS1 (green; antibody 17.2) indicating the overlap of staining within the extending processes and terminals (arrow) (B).
transgenic cultures was limited to the human protein (not shown). This is consistent with the Western blots probed with the NT1 antibody where no immunoreactive bands were observed for endogenous mouse PS1. These observations indicate that the introduction of transgenic PS1, and M146L (B) mutant proteins using the human-specific antibody NT1. Labeling comparable to that of the endogenous mouse PS1 was observed, although with a more punctate distribution.
either wild-type or mutant, does not cause any obvious abnormalities in the patterns of PSI distribution.
Discussion
In the present study, we have examined the cell biology of PSI in hippocampal neurons derived from wild-type mice as well as neurons from transgenic mice expressing wild-type or mutant human PSI. The objective of this investigation was to determine the processing and subcellular distribution of mutant and wild-type PSI at various developmental stages. A comparative study of the endogenous mouse and human PSI transgenic neurons allowed us to determine whether there might be any obvious differences in the behavior of the normal human PS 1 protein or in a mutated counterpart. In addition, this investigation allowed us to establish the feasibility of using these neuronal cultures to investigate the relationship of presenilins to AD-related pathobiology.
Previous investigations have revealed that PSI undergoes endoproteolytic cleavage at or near Met-292 which is located within the cytoplasmic loop (52) . This results in the formation of an -30 kD PS1-NTF and an -20 kD PS1-CTF fragment (5, 52) . The majority of PSI exists in a cleaved state which appears to be highly stable as shown by the extended half-lives of the endoproteolytic fragments (5, 7, 49, 52) . In contrast, PS i-FL is rapidly degraded, possibly by a proteasome-mediated pathway (57) . Examination of the transgenic and nontransgenic cultured neurons indicated that endogenous murine and transgenic human wild-type and mutant PSI were all processed in a comparable fashion, based upon immunoblotting of major fragments using a variety of antibodies. In all cases, PSINTFs and CTFs behaved similarly in expression and cleavage state at all stages of development. Detectable levels of the full-length PSI were only observed at the final stages of differentiation. We found an indistinguishable pattern for the M146L mutant (i.e., early appearance of the endoproteolytic fragments with same accumulation of the full-length protein at later stages). These results suggest that, at the level of PSI processing, the human wild-type and mutant PS1 proteins behave similarly to the endogenous mouse protein.
The availability of a human PS i-specific MAb permitted us to follow the processing of the transgenic proteins without interference from the endogenous murine PS1. Consistent with previous findings, the human wtPS 1 appeared as proteolytic fragments. However, compared to murine PS1, the level of the full-length human PSI was considerably lower, even in fully differentiated neurons. The reduction in human PS i-FL may be due either to the expression level or to preferential cleavage of the human protein.
Another unique feature of the human PSI protein was the presence of electrophoretic heterogeneity of its N-terminal fragments, which appeared as a major species at -33 kD and a less prominent and slightly more rapidly migrating species. This was also observed using the crossreactive polyclonal antibodies. The origin and potential biological function of this minor species is unknown but our investigations with the human-specific antibody have revealed that both fragments are derived from the human PSI protein, and may therefore originate from an alter-native cleavage pathway. Multiple N-terminal fragments have been observed in differentiating rat cultures (51) and in the developing human brain (45, 52) . Alternatively, they may arise from distinct post-translational modifications such as phosphorylation (7, 58 ). These observations demonstrate not only that the post-translational modification of transgenic PSI is developmentally regulated but also that human PSI metabolism in neuronal cultures from transgenic animals parallels that of the human brain.
Further investigations of the biology of the murine and transgenic PSI were performed to determine their distribution and subcellular localization during development. As with endoproteolysis, comparisons of PSI localization in the different cultures indicated that the endogenous and wild-type human transgenic PS I were distributed in a similar manner. Both human and murine PS1 were initially concentrated within the perinuclear space, and overlapped to a large extent with ER and CGN markers such as BiP and p58. This is consistent with previous observations in transfected cells and in rat neuronal cultures (20, 21, 51, 59, 60) . In contrast to that observed in non-neuronal cells, PSI distribution in hippocampal cultures was not restricted to perinuclear compartments but appeared to be much more widespread. At later stages of development, PSI immunoreactivity was observed within the processes and appeared to be distributed in both axons and dendrites. It is possible that this virtually contiguous staining from the cell body into the processes is the result of ER-resident PS1 as it has been shown that the smooth ER can extend for long distances within neurites (54) . However, the punctate labeling pattern is more suggestive of a discrete vesicular localization. These structures could, for example, reflect the association of PSI with the machinery of anterograde and/or retrograde vesicular transport. Immunofluorescence studies with the human PSI-specific mAb NT1 revealed the most striking punctate staining. Because this antibody exclusively recognizes the human fragments and low levels of the full-length human PSI protein was present in the cultures, these results may indicate that fragments of the human PSI preferentially localize to vesicles and/or that the proteins are sequestered to particular compartments following cleavage.
Interestingly, some of the most intense PSI immunostaining was observed within the extending growth cones as shown by overlap with GAP43 immunoreactivity. This concentration of PSI at the process terminals raises the possibility that the presenilins are involved in synaptic contacts. The recent report that the PSI cytoplasmic loop forms a stable complex with ,3-catenin and a novel armadillo protein is consistent with a proposed functional interaction in synaptic development (9, 61) . It has been demonstrated that cell-cell adhesion mediated by the cadherincatenin complex is localized to synapses and may be responsible for maintaining the synaptic ultrastructure possibly via direct interactions with the actin network (62) . This hypothesis is supported by recent fractionation studies demonstrating the association of endogenous rat PSI with synaptic organelles and growth cone membranes (63) . Although this requires further investigation, the growth cone localization of PSI may be indicative of a larger functional complex with the catenins and other underlying cytoskeletal elements.
The object of our investigation was to determine the behavior of the presenilins in neuronal cultures and to ascertain whether any differences were readily apparent between the endogenous murine PS I and the transgenic human wild-type or mutant proteins. Based upon immunoblotting and immunofluorescence studies at different stages of development, it appears that the wildtype human transgenic PSI is generally handled in a fashion comparable to the endogenous mouse protein, although some minor differences in N-terminal processing were observed. This was also true for the human PSI M146L mutant which was processed and localized in a similar fashion. This suggests that there are no overt differences in the metabolism or subcellular distribution of the mutant PSI as compared to human wild type. Therefore, the pathological changes associated with PSI mutations, such as the abnormalities in APP processing, must arise from more subtle mutation-related changes in presenilin function. The observed similarities in the biology of the transgenic PSI proteins are also important in that they indicate that these cultures may be useful models to investigate further presenilin function and its relationship to AD-related pathology. Finally, the widespread distribution of the presenilins in various subcellular localization such as the ER, Golgi, and growth cones suggests that PS1 may be involved in several pathways. Use of hippocampal cultures should help to clarify both the normal and pathological functions of the presenilins.
